Joseph Hagan Net Worth & Insider Trades

Joseph Hagan - President and CEO, Regulus Therapeutics Inc

As of January 17, 2023

What is Joseph Hagan's Net Worth?

The current estimated net worth of Regulus Therapeutics Inc's President and CEO, Joseph Hagan, is estimated to be about $1.33M . Joseph Hagan owns about 417,006 units of Regulus Therapeutics Inc common stock. In the last 7 years at Regulus Therapeutics Inc, Joseph Hagan has sold an estimated value of $104.42K worth.

What is Joseph Hagan's Past Insider Trading?

Joseph Hagan's largest purchase order was 219,780 units , worth over $200K on July 25, 2017. Joseph Hagan's largest sale order was 39,352 units , worth over $47.97K on May 16, 2019. In total, Joseph Hagan has made about 33 transactions over 7 years of their time at Regulus Therapeutics Inc. Joseph Hagan usually trades in May, with the busiest year in 2019. The most recent transaction was a purchase order of 100,000 units , worth over $21.52K on January 26, 2022.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

What is Joseph Hagan's' Mailing Address?

  • Mailing address is 3344 N. Torrey Pines Court, Suite 200 La Jolla CA 92037 CA

What are Regulus Therapeutics Inc's Past Insider Trades?

Regulus Therapeutics Inc's most recent insider trade came on March 1, 2022 by Denis Drygin who bought 76,686 units worth $17.64K . In the last 10 years, insiders at Regulus Therapeutics Inc have sold an estimated value of $79.77M and bought an estimated value of $68.69M worth of shares. Insider trading is most common in June, with the busiest year in 2019. The most active traders at the company are Joseph Hagan, President and CEO,  Stelios Papadopoulos, Director,  and Christopher Aker, Sr. VP & General Counsel .

Regulus Therapeutics Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...